IL-27 rs153109 polymorphism increases the risk of colorectal cancer in Chinese Han population

• Main Authors: Lyu SX, Ye LC, Wang OC, Huang GL, Yang F, Liu YH, Dong SY
• Format: Article
• Language: English
• Published: Dove Medical Press 2015-06-01
• Series: OncoTargets and Therapy
• Online Access: http://www.dovepress.com/il-27-rs153109-polymorphism-increases-the-risk-of-colorectal-cancer-in-peer-reviewed-article-OTT

Shixu Lyu, Lechi Ye, Ouchen Wang, Guanli Huang, Fan Yang, Yehuan Liu, Siyang Dong Department of Surgical Oncology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China Abstract: IL-27, a new member of the IL-12 family, has been found to have antitumor effects in colorectal cancer (CRC); therefore, polymorphisms of this protein may modulate CRC carcinogenesis. So, we studied the association of single nucleotide polymorphisms of the IL-27 gene with the risk of CRC occurrence using a case–control using 600 CRC patients and matched healthy controls. The IL-27 rs153109 polymorphism was analyzed with polymerase chain reaction-restriction fragment length polymorphism and DNA sequencing methods. Data indicate that GG, GA, and combined A-variant genotypes (GG + GA) conferred significantly greater risk of CRC (P=0.034, 0.002, and 0.001, respectively), and that G alleles were associated with higher susceptibility to CRC (P=0.001). However, no correlation was found between the IL-27 rs153109 polymorphism and particular clinical features. In conclusion, our data demonstrated a clear association of IL-27 rs153109 polymorphism and the risk of CRC development. Keywords: IL-27, polymorphism, CRC